Mandatory Disclosure And Cooperation To Be Proposed For Commercial Item And Overseas Contractors
Client Alert | 1 min read | 04.16.08
In a hearing before the House Oversight and Government Reform Committee on April 15, 2008, the Administrator for Federal Procurement Policy indicated that he is inclined to issue a new proposed rule that would subject commercial item contracts and contracts performed overseas to mandatory disclosure to the agency inspector general when the contractor "has reasonable grounds to believe that a principal, employee, agency, or subcontractor of the [c]ontractor has committed a violation of Federal criminal law in connection with the award or performance of [a] contract or any subcontract thereunder." Such proposed rule would also modify a November 14, 2007 proposal, discussed in the linked article by C&M's Angela Styles, to mandate "[f]ull cooperation with Government agencies responsible for audit, investigation, or corrective action" for commercial item and overseas contracts.
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
